文献速递糖尿病肥胖与代谢综合征

胃旁路手术对肥胖1型糖尿病患者的潜在获益与风险:全国匹配观察性队列研究

Potential Benefits and Harms of Gastric Bypass Surgery in Obese Individuals With Type 1 Diabetes: A Nationwide, Matched, Observational Cohort Study.
PubMed 文献 · Diabetes Care · 2020-10-06

该全国性匹配队列研究比较了387例接受Roux-en-Y胃旁路术(RYGB)的肥胖1型糖尿病(T1D)患者与387例未手术匹配对照。随访发现RYGB组心血管疾病、心血管死亡、心衰住院和卒中风险更低,但严重高血糖事件和物质滥用风险更高。提示手术可能带来类似2型糖尿病的心血管获益,但需警惕严重不良事件。

要点

  • RYGB与T1D肥胖患者心血管疾病和死亡风险降低相关
  • 术后严重高血糖事件和物质滥用风险增加,需密切监测
  • 该观察性研究支持在T1D肥胖患者中权衡手术获益与风险

核心结论

  • 观察性研究提示,RYGB可能使肥胖T1D患者获得与2型糖尿病相似的心血管结局和死亡获益,但存在严重不良效应需术后密切监测。

研究设计与样本

  • 基于瑞典国家糖尿病登记和斯堪的纳维亚肥胖手术登记链接的全国性匹配观察性队列研究,纳入2007至2013年个体。
  • 比较387例接受RYGB的T1D肥胖患者与387例按年龄、性别、BMI和日历时间匹配的未手术T1D肥胖患者。
  • 住院随访最长9年,评估全因死亡、心血管疾病、卒中、心衰、严重低/高血糖住院、截肢、精神疾病、肾功能变化和物质滥用等结局。

主要发现

  • RYGB组心血管疾病风险更低(HR 0.43;95% CI 0.20-0.9)。
  • RYGB组心血管死亡风险更低(HR 0.15;95% CI 0.03-0.68)。
  • RYGB组心衰住院风险更低(HR 0.32;95% CI 0.15-0.67)。
  • RYGB组卒中风险更低(HR 0.18;95% CI 0.04-0.82)。
  • RYGB组术后严重高血糖事件风险更高(HR 1.99;95% CI 1.07-3.72),物质滥用风险更高(HR 3.71;95% CI 1.03-3.29)。

临床怎么用

  • 对肥胖T1D患者考虑RYGB时,应综合评估心血管获益与术后严重高血糖及物质滥用风险。
  • 术后需加强对严重高血糖事件和物质滥用的监测与管理。

局限性

  • 本研究为观察性设计,可能存在残余混杂,无法确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the potential long-term benefits and possible complications of bariatric surgery in patients with type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: In this register-based nationwide cohort study, we compared individuals with T1D and obesity who underwent Roux-en-Y gastric bypass (RYGB) surgery with patients with T1D and obesity matched for age, sex, BMI, and calendar time that did not undergo surgery. By linking the Swedish National Diabetes Register and Scandinavian Obesity Surgery Registry study individuals were included between 2007 and 2013. Outcomes examined included all-cause mortality, cardiovascular disease, stroke, heart failure, and hospitalization for serious hypo- or hyperglycemic events, amputation, psychiatric disorders, changes in kidney function, and substance abuse. RESULTS: We identified 387 individuals who had undergone RYGB and 387 control patients. Follow-up for hospitalization was up to 9 years. Analysis showed lower risk for cardiovascular disease (hazard ratio [HR] 0.43; 95% CI 0.20-0.9), cardiovascular death (HR 0.15; 95% CI 0.03-0.68), hospitalization for heart failure (HR 0.32; 95% CI 0.15-0.67), and stroke (HR 0.18; 95% CI 0.04-0.82) for the RYGB group. There was a higher risk for serious hyperglycemic events (HR 1.99; 95% CI 1.07-3.72) and substance abuse (HR 3.71; 95% CI 1.03-3.29) after surgery. CONCLUSIONS: This observational study suggests bariatric surgery may yield similar benefits on risk for cardiovascular outcomes and mortality in patients with T1D and obesity as for patients with type 2 diabetes. However, some potential serious adverse effects suggest need for careful monitoring of such patients after surgery.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Höskuldsdóttir G, Ekelund J, Miftaraj M, et al. Potential Benefits and Harms of Gastric Bypass Surgery in Obese Individuals With Type 1 Diabetes: A Nationwide, Matched, Observational Cohort Study. Diabetes Care. 2020. PMID: 33023988. doi:10.2337/dc20-0388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。